Actively Recruiting

Age: 18Years +
All Genders
ID06773611

Electronic Register on Advanced Heart Failure and Transplantation

Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-14

10000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are creating an electronic registry of patients diagnosed with Advanced Heart Failure or those who have had a Heart Transplant, tracking cases starting from January 1, 1985. This observational study aims to understand how often these conditions occur and to describe the characteristics of patients facing these serious heart conditions. The study looks at important outcomes like hospitalization due to heart-related causes and death over a five-year period. This study includes both past and ongoing data collection, reviewing information retrospectively and prospectively to gather a comprehensive view of patient experiences. Treatments for heart failure range widely, including medications, lifestyle changes, device implants, and heart transplant surgeries. The study does not assign treatments but collects detailed patient information to evaluate the impact of these approaches and disease progression. Participants will be regularly monitored through their medical records to assess hospitalizations, death events, and other health-related factors like device implantations or need for additional therapies. The study tracks these outcomes over five years to better understand patient health and disease management. Participation involves data collection without altering usual care, and there is no maximum age limit for involvement.

CONDITIONS

Brief Title

Electronic Register on Advanced Heart Failure and Transplantation di Cuore

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 63 18 years
  • Ability to provide informed consent
  • Diagnosis of Advanced Heart Failure or Heart Transplant
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Long-term Monitoring

Duration - Up to 5 years

Participants who have advanced heart failure or a heart transplant are observed over time to assess their health status and outcomes such as hospitalizations and survival.

Regular check-ups over 5 years

Trial Site Locations

Total: 1 location

1

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Bologna, Italy, 40138

Actively Recruiting

Loading map...

Research Team

L

Luciano Potena, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Extensive Post-discharge Counselling and Phone-based Follow-...

Heart Failure

Actively Recruiting

1 location

Three-Dimensional Assessment of Right Ventricular Function i...

Heart Failure

Actively Recruiting

1 location

Myocardial Fibrosis in Heart Failure: A Pilot Study Using 68...

Myocardial Fibrosis

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here